Low-dose Sargramostim Shows Promise in Small Early Trial
Treatment with a low dose of the immune-modulating medication sargramostim was well-tolerated and eased motor symptoms in a small clinical…
Articles by Marisa Wexler, MS
US Economic, Social Cost of Advanced Parkinson’s in Billions, Study Says
Limitations in functional abilities due to advanced Parkinson’s disease result in billions of dollars of lost economic value in…
Non-motor Symptoms Determine Quality of Life After DBS
Non-motor symptoms are major determinants of quality of life (QOL) for people with Parkinson’s disease who have undergone…
New Rasagiline Formulation May Allow Application to Skin
A new formulation of rasagiline, approved for Parkinson’s disease, may allow the therapy to be given by applying…
Salivary Caffeine Levels Decreased in Some Patients
People with moderate or advanced Parkinson’s disease have abnormally low levels of caffeine in their saliva, despite normal caffeine…
Study Uncovers Genetic Variants Linked to Disease Progression
Scientists have identified genetic variations that are associated with different rates of disease progression in people with Parkinson’s disease.
MJFF’s Virtual Walk or Run for Parkinson’s Research Set for May 7-9
The Michael J. Fox Foundation (MJFF) is hosting its second virtual walk event this weekend, and for the first…
#AANAM – SEP‑363856 Shows Promise in Easing Parkinson’s Psychosis
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April…
Neurons, Not Nearby Cells, Decide Dopamine Levels, Study Reports
Dopamine-releasing cells in the brain, much like most other hormone-producing cells, have a self-regulating feedback mechanism that controls their activity,…
Project to Explore if Depression Meds Might Ease Dyskinesia Due to L-dopa
A new research project aims to determine whether medications developed to treat depression might be viable candidates for easing some…